October 13, 2016 / 5:06 AM / 9 months ago

BRIEF-Gensight Biologics reports cash position as of September 30, 2016

1 Min Read

Oct 13 (Reuters) - Gensight Biologics SA :

* Reports Its Cash Position As Of September 30, 2016

* Cash and cash equivalents amounted to 57.8 million euros ($64.74 million) as of September 30, 2016, compared to 19.1 million euros as of June 30, 2016. Source text for Eikon: Further company coverage: ($1 = 0.8928 euros) (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below